BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 17, 2005
View Archived Issues
PDE3/4 inhibitors activate CFTR in a cell culture model
Read More
PEP-005 IV shows efficacy in mouse model of acute myeloid leukemia
Read More
Phase II data on tadalafil in the treatment of BPH
Read More
VRC begins phase II testing of HIV vaccine developed with GenVec
Read More
CepTor plans IND for Myodur, seeks orphan drug designation
Read More
Phase I study for Fx-1006A to stabilize protein misfolding in hereditary amyloid disorders
Read More
Locus establishes Oncology Advisory Board
Read More
Enrollment completed in ORIENT studies of olmesartan in diabetic nephropathy
Read More
Updated HIV/AIDS treatment guidelines support Fuzeon + PI use
Read More
European orphan drug status recommended for tilarginine acetate injection
Read More
MM-093 studied in phase IIa trial for psoriasis
Read More
Speedel begins clinical testing of new renin inhibitor SPP-635
Read More
Altana presents pipeline overview
Read More
Exubera recommended for approval in Europe
Read More
Alteplase receives new approval in Japan
Read More
Recent patents cover therapeutic agents for neurological disorders
Read More
Novel agents imparted for the treatment of autoimmune and inflammatory disorders
Read More
Treatments for cancer in early development
Read More
New data on the antifungal effects of R-126638
Read More
Licochalcone A-based skin care products reduce erythema in rosacea
Read More
Phase III data on the therapeutic benefits of BG-00012 in psoriasis
Read More
CNTO-1275 improves symptoms, quality of life of patients with moderate to severe psoriasis
Read More
Granisetron shows promise in the treatment of rosacea
Read More
Results with rifaximin encouraging in Crohn's disease study
Read More
Balsalazide reduces proctosigmoiditis in radiotherapy-treated prostate cancer patients
Read More
